New Test For Breast Cancer Making Individualized Treatment Decisions A

| Total Words: 607

New Test For Breast Cancer Making Individualized Treatment Decisions A Reality

Widely hailed as the next frontier in medical advances, the promise of individualized medicine is becoming a reality thanks to progress in understanding the molecular basis of diseases such as breast cancer. Scientists can now develop treatments that are tailored to individual genetic profiles, as well as tests to predict how a patient will respond to existing therapies.

Today, some women with early-stage breast cancer and their physicians can make more informed treatment decisions with the Oncotype DX Breast Cancer Assay. This service provides quantitative information about genes from a woman’s individual tumor to generate a Recurrence Score between zero and 100, indicating whether she is at high, intermediate or low risk for her cancer returning after treatment.

Oncotype DX is intended for patients with node-negative, estrogen receptor-positive breast cancer who are likely to be treated with hormonal therapy. Approximately half of the 230,000 patients diagnosed with breast cancer in the United States each year fall into this category, and are frequently offered treatment...

To view and download this full PLR article, you must be logged in. Registration is completely free. Once you create your account, you will be able to browse, search & downlod from our PLR articles database of over "1,57,897+" on 1,000's of niches and 200+ categories without paying a penny. Click here to signup...

Recommended Products You Might Like

Cancer PLR Article

Price: $1.97
Download Now

Drink To Prevent Cancer Personal Use Ebook

Price: $1.97
Download Now

How To Quit Smoking PLR Ebook

Price: $1.97
Download Now

** TEXT to VIDEO: Create Awesome Videos From Text... FAST!...